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Abstract
Animal models of human disease are an invaluable component of studies aimed at understanding disease pathogenesis and
therapeutic possibilities. Mutations in the gene encoding retinitis pigmentosa GTPase regulator (RPGR) are the most
common cause of X-linked retinitis pigmentosa (XLRP) and are estimated to cause 20% of all retinal dystrophy cases. A
majority of RPGR mutations are present in ORF15, the purine-rich terminal exon of the predominant splice-variant expressed
in retina. Here we describe the genetic and phenotypic characterization of the retinal degeneration 9 (Rd9) strain of mice, a
naturally occurring animal model of XLRP. Rd9 mice were found to carry a 32-base-pair duplication within ORF15 that
causes a shift in the reading frame that introduces a premature-stop codon. Rpgr ORF15 transcripts, but not protein, were
detected in retinas from Rd9/Y male mice that exhibited retinal pathology, including pigment loss and slowly progressing
decrease in outer nuclear layer thickness. The levels of rhodopsin and transducin in rod outer segments were also
decreased, and M-cone opsin appeared mislocalized within cone photoreceptors. In addition, electroretinogram (ERG) a-
and b-wave amplitudes of both Rd9/Y male and Rd9/Rd9 female mice showed moderate gradual reduction that continued
to 24 months of age. The presence of multiple retinal features that correlate with findings in individuals with XLRP identifies
Rd9 as a valuable model for use in gaining insight into ORF15-associated disease progression and pathogenesis, as well as
accelerating the development and testing of therapeutic strategies for this common form of retinal dystrophy.
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Introduction
Retinitis pigmentosa (RP) is a group of clinically and genetically
heterogeneous progressive retinal degenerative disorders that are
characterized by rod and cone photoreceptor dysfunction and
death, and which often culminate in blindness [1]. X-linked forms
of RP (XLRP) are among the most severe [2], comprising an
estimated 15% of total non-syndromic, non-systemic cases [3,4].
Six genetic loci have been mapped for XLRP; of these, RP3 is the
predominant subtype (www.sph.uth.tmc.edu/retnet/). RP3 is
associated with mutations in the gene encoding Retinitis
Pigmentosa GTPase Regulator (RPGR), which encodes multiple
alternatively-spliced forms that all share a common amino-
terminal domain with homology to Regulator of Chromosome
Condensation 1 (RCC1) [4,5]. The major form of RPGR detected
in most tissues (the constitutive form) is produced by exons 1 to 19,
whereas the predominant form of RPGR in retina results from an
alternatively-spliced transcript containing a unique terminal exon,
ORF15. Mutations in ORF15 account for the majority of RP3
cases, and thus, this region is considered to be a mutation ‘hotspot’
[3–5]. To date, all of these mutations are deletions or duplications
of purine-rich repeats in ORF15 that produce shifts in the reading
frame which predict premature termination of translation.
RPGR mutations are often associated with rod-cone degenera-
tion that is highly variable in degree of severity. Affected males
generally show signs of night blindness by the first decade of life,
progressing to vision loss by the fourth decade [6–9]. Female
carriers can at times exhibit clinical findings, including electroret-
inogram (ERG) defects [6,7,10]. In some instances, RPGR
mutations are associated with cone-rod degeneration, atrophic
macular degeneration, and syndromic phenotypes [4,11–13].
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isoprenylation sequence and is detected in Golgi complex [14],
whereas RPGR-ORF15 localizes to centrosome in cultured cells
[15] and predominantly to the transition zone of the photorecep-
tor cilium [16,17]. RPGR can interact or exist in complexes with
multiple transport and/or ciliopathy-associated proteins, including
RPGRIP1, RPGRIP1L, NPHP5 and CEP290 [17–23].
To understand the pathogenesis of retinal degeneration, animal
models have been used to study RPGR function. Rpgr-knockdown
in zebrafish resulted in severe developmental abnormalities,
including those associated with ciliary function [24,25]. However,
complete loss of Rpgr protein in knockout mice (Rpgr-KO),
generated by deletion of exons 4 to 6, led to a relatively slow
photoreceptor degeneration phenotype [26]. A second strain of
mutant mice, generated by deletion of Rpgr exon 4, exhibited a
variable phenotype depending on the genetic background,
resulting in either rod- or cone-dominated disease [27]. Two
canine mutants (XLPRA1 and XLPRA2) resulting from nonsense
and frame-shift mutations in RPGR ORF15, respectively, demon-
strated distinct patterns of progression of X-linked retinal atrophy
[28]. These canine models have provided an excellent platform to
study disease progression and evaluate the efficacy of gene-
replacement therapy [29]; however, corresponding mouse models
with a relatively shorter generation time have the potential to
significantly accelerate progress in defining RPGR-ORF15
function, as well as the cell biological and biochemical bases of
the disease associated with ORF15 mutations. Combining studies
in mice with those in other animal models is thus predicted to
rapidly advance understanding of the phenotypic variations and
pathogenesis associated with RPGR mutations, as well as the
effectiveness of novel therapeutic strategies.
We now describe the genetic, phenotypic and biochemical
characterization of Rd9 mice that were previously identified
among the strains curated by The Jackson Laboratory as a
naturally occurring model of X-linked retinal degeneration present
on the C57BL/6J (B6) background [30]. We have identified a
disease-associated mutation in mouse Rpgr ORF15 that is similar
to mutations identified in many XLRP patients. Rd9/Y male mice
do not express the Rpgr-ORF15 isoform, which in turn affects the
expression of other photoreceptor proteins. We also describe in
detail the Rd9 retinal phenotype. Our studies suggest that Rd9 is
an excellent mouse model for investigating the retinal degenera-
tion caused by ORF15 mutations, as well as for developing gene-
based and other therapies.
Materials and Methods
Animals
Experimental procedures involving animals were performed in
accordance with the guidelines and under the approval of the
University Committee on Use and Care of Animals at the
University of Michigan, the Institutional Animal Care and Use
Committee at The Jackson Laboratory, and the Animal Care and
Use Committee at the National Eye Institute; and were in
compliance with the statement for ethical care and use of animals
of the Association for Research in Vision and Ophthalmology
(ARVO). Mice were raised in 12-hour on/12-hour off cyclic
lighting. For linkage mapping, extensive backcrosses were carried
out between (CAST/Rd9)F1 and C57BL/6J, resulting in the
generation of over 360 meioses with different haplotypes. Fundus
photography was performed after pupil dilation with 1% atropine,
and images were captured using a Genesis small animal fundus
camera (Kowa, Torrance, CA) fitted with a 90-diopter condensing
lens.
PCR and Sequence Analysis
Genomic DNA was extracted from tail snips and retinas from
Rd9 and wild-type C57BL/6J (B6) mice using Puregene reagents
(Gentra, Minneapolis, MN). Total retinal RNA was isolated using
RNAqueous (Ambion, Austin, TX) and first strand cDNAs were
generated using oligo-dT primers and Superscript II (Invitrogen,
Carlsbad, CA). RT-PCR amplifications were performed using the
Expand Long Template PCR system (Roche, Indianapolis, IN)
and Rpgr-specific primers (see Table S1 for all primer sequences).
For sequencing Rpgr exons 1–19, the cDNAs were PCR amplified
and gel-purified products were sequenced using the same primers.
For sequencing exon ORF15, genomic DNAs were amplified
using AccuPrime high fidelity Taq polymerase (Invitrogen,
Carlsbad, CA) and Rap3 and P7 primers, and the 2.2 kb gel-
purified products were sequenced using the same primers, as well
as the internal primers F208 and R1476.
Immunoblot Analysis
Rod outer segments (ROS) from male Rd9/Y mice (1 month-
of-age) in room light were prepared by gradient centrifugation
[31]. Extracts of total retinal proteins were generated by
homogenizing dissected retinas in phosphate buffered saline
(PBS) plus protease inhibitors, and cellular debris was removed
by centrifugation. Protein concentrations were determined using
Micro BCA assay kit (Pierce, Rockford, IL). Immunoblot analysis
was performed using standard methods with primary antibodies
against RPGR [26,32], rhodopsin [33], transducin-alpha subunit
(GeneTex, Irvine, CA), arrestin (ABR AffinityBioreagents, Gold-
en, CO), and recoverin (Chemicon, Billerica, MA), and reactivity
was visualized using alkaline phosphatase-conjugated secondary
antibodies and reagents (Sigma-Aldrich, St. Louis, MO).
Immunohistochemistry and Retinal Histology
For immunohistochemical analysis, mice were anesthetized and
perfused with 4% paraformaldehyde, the eyes were enucleated
and transitioned to sucrose:OCT, and flash frozen. Cryosections
(10 mm) were incubated with primary antibodies against rhodopsin
[33], S-opsin and M-opsin (Chemicon, 1:500), and labeling was
visualized using goat anti-rabbit AlexaFluor-488 secondary
antibody and standard methods [34]. For analysis of retinal
histology, anaesthetized mice were perfused with 2% paraformal-
dehyde plus 2% glutaraldehyde, the eyes were enucleated and
post-fixed at least 1 h, and then dehydrated and embedded in JB-4
plastic. Sections (5 mm) were stained with Lee’s stain, and imaged
on a fluorescence microscope with digital camera. Measurements
of retina layer thickness were made on sections parallel (superior,
inferior) and orthogonal (nasal, temporal) to the vertical meridian
of the eye, and were plotted vs. distance from the optic nerve head
[35]. The statistical significance of differences between the two
groups (B6 vs. Rd9) was evaluated by Wilcoxon and t-tests using
mixed linear regression.
Electroretinography
ERGs were performed as described previously [36,37] using the
Espion e
2 recording system (Diagnosys, Lowell, MA). Briefly, mice
were dark-adapted overnight and anesthetized with an intra-
peritoneal injection of Ketamine (93 mg/kg) and Xylazine (8 mg/
kg). Pupils were dilated with topical atropine (1%) and tropicamide
(0.5%). Body temperature was maintained at 37uC with a heating
pad. Corneal ERGs were recorded from both eyes using gold wire
loops with 0.5% tetracaine topical anesthesia and a drop of 2%
methylcellulose for corneal hydration. A gold wire loop placed in
the mouth was used as reference, and a ground electrode was on
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ERGs to brief white flashes from 25.8 to +1.09 log cd.s.m
–2/flash
in steps of 0.5 log units. Responses were amplified at 1,000 gain at
1.25 to 1000 Hz, and digitized at a rate of 2000 Hz. A notch filter
was used to remove 60 Hz line noise. Responses were computer
averaged and recorded at 3 to 60 s intervals depending upon the
stimulus intensity. Light-adapted ERGs were recorded after 10
minutes of adaptation to a white 32 cd.m
–2 rod-suppressing
background. ERGs were recorded for stimulus intensities from –
0.91 to +1.09 log cd.s.m
–2 over a 2 log unit range in steps of 0.3
log units. A white 2.0 log cd.s.m
–2 was used to record the photopic
negative response (PhNR), which originates from the ganglion cells
[38,39]. ERG analysis was performed on Rd9/Y male mice
(n=56, ages 1 to 24 months), Rd9/Rd9 female mice (n=15, ages
1 to 20 months), and wild-type B6 mice (n=35, ages 1 to 24
months).
Results
Rd9 Fundus Features
Rd9 mice were originally identified as a naturally occurring
retinal degeneration strain on the basis of pathological findings
evident on indirect ophthalmoscopy. Comparison of images from
Rd9 and wild-type B6 mice showed unique changes in Rd9/Y
male mice at ages as young as 5 months old; these included retinas
with ‘‘creamy blonde’’ appearance and pronounced loss of
pigment (Figure S1, top). Fluorescein angiography showed
telangiectasia and some leakage from vessels (Figure S1, bottom).
Fundus photographs of Rd9/Rd9 females appeared similar to
those of Rd9/Y males, while photographs of Rd9/+ females
showed only diffuse white spots.
Genetic Analysis and Identification of Rpgr-ORF15
Mutation in Rd9
Extensive backcrosses of Rd9 mice ((CAST/Rd9)F16B6),
combined with genotyping of 364 informative meioses, mapped
the Rd9 mutation to the X-chromosome between markers
DXMit55 and DXMit224 (Figure 1A), a region syntenic with the
human Xp21.1 (XLRP-RP3-RPGR) locus. Analysis of the
constitutively-expressed Rpgr isoform (exons 1–19) revealed no
sequence change between Rd9 and wild-type B6 mice. However,
sequence analysis of the alternatively-spliced Rpgr exon ORF15
identified a 32-bp duplication in Rd9 genomic DNA that was not
present in B6 DNA (Figure 1B and 1C). Due to the repetitive
nature of the sequence, the exact position of the 32-bp duplication
is difficult to assign. In the Rd9 ORF15 sequence, six 32-bp
repeats are present. For the first five, these repeats are separated
by a 4-nucleotide sequence. However, the sixth repeat begins
immediately following the end of the fifth repeat, suggesting that
the duplication is after position 687 of ORF15, as shown in
Figure 1C. The duplication produces a frame shift in the repetitive
region of ORF15, predicting a truncated protein in which the C-
terminal 108 amino acids are unrelated to the wild-type Rpgr
protein and are predominantly basic (61%) (Figure 1D).
The ORF15 sequence from another wild-type strain, 129/SvJ,
was also examined for comparison to Rd9. The 129/SvJ sequence
has an in-frame 72-bp duplication and an in-frame insertion
compared to the B6 sequence; however, again, precise placement
of the duplication and insertion is not possible because of the
repetitive nature of this sequence (Figure 1C).
The sequence of ORF15 from C57BL/6 present in the UCSC
Genome Browser was found to be 31 nucleotides shorter than our
ORF15 sequence from B6 (Figure 1C). This 31-bp deletion would
cause a frame-shift and result in a severely truncated Rpgr protein.
The deletion may represent an intra-strain variant, or a
sequencing error in the UCSC C57BL/6 sequence, an issue that
will require further studies to resolve.
Rpgr mRNA and Protein Expression in Rd9 Retina
RT-PCR analysis was performed using total retinal RNA from
3-month-old Rd9, B6, and Rpgr-KO mice to examine major
alternatively spliced forms of Rpgr mRNA. Both Rd9 and B6
strains exhibited PCR products corresponding to Rpgr 1-ORF15
and exon 1–19 (Figure 2B). In contrast, these Rpgr transcripts
appeared substantially reduced or absent from Rpgr-KO mice, as
shown previously [26].
Immunoblot analysis was performed using retinal protein lysates
from Rd9, B6, and Rpgr-KO mice at 2 and 6 months-of-age. The
antibodies used recognized Rpgr epitopes shared by both variants
(S1), or present in the constitutive variant only (S3) (Figure 2A)
(16). In B6 mouse retina, the Rpgr-ORF15 isoform (<250 kDa)
was recognized by S1 antibody, whereas the constitutive Rpgr 1–
19 isoform (<98 kDa) was recognized by both S1 and S3
antibodies (Figure 2C). In retinal lysates from Rd9 mice, the
Rpgr 1–19 isoform was present, but no Rpgr-ORF15 isoform was
detected. Retinal extracts from Rpgr-KO mice showed no specific
reactivity with either antibody, indicating the absence of both
major Rpgr isoforms.
The expression of Rpgr variants was also investigated using
immunohistochemistry on retina sections from 3-month-old Rd9/
Y, B6, and Rpgr-KO mice. The S1 antibody that recognizes both
constitutive and ORF15 isoforms showed strong immunostaining
in the photoreceptor connecting cilium of B6 mice, but little
reactivity was observed in Rd9 retinas (Figure 3). The S3 antibody
that recognizes only the constitutive isoform showed low-level
immunoreactivity in photoreceptor inner segments of B6 mice,
and this staining was further reduced in Rd9 retinas. No S1 or S3
immunoreactivity was detected in Rpgr-KO retinas, as reported
previously [26]. Our data are consistent with reports that the
Rpgr-ORF15 isoform is present primarily in the photoreceptor
connecting cilium, whereas the constitutive Rpgr 1–19 isoform is
present in the cytosol [16,32].
Rd9 Retinal Histology
Retina sections from Rd9/Y mice showed largely normal
structure and outer nuclear layer (ONL) thickness in animals 1 and
2 months-of-age (Figure 4A). For young animals, morphometric
analysis demonstrated equivalent thickness of retinal cell layers in
Rd9/Y and wild-type B6 mice, except for a slightly smaller
combined length of outer plus inner segments (OS+IS) in the
Rd9/Y superior and temporal regions (data not shown). This
profile of OS+IS length persisted essentially unchanged up to 12
months-of-age (Figure 4B). Although the figures and data show a
trend toward differences in the OS+IS thickness, overall analysis
across all locations (by mixed regression) does not reach statistical
significance (p=0.07). During aging, Rd9/Y mice exhibited a
gradual loss of ONL cell counts and overall decrease in
photoreceptor layer thickness, while the inner retina appeared
relatively well preserved. Morphometric analysis of ONL thickness
in Rd9/Y mice at 12 months-of-age showed significant decreases
in the superior, inferior, and temporal regions (p,0.05)
(Figure 4C). By 24 months-of-age, the overall thickness of the
photoreceptor layer in Rd9/Y mice was approximately half that at
1 month-of-age.
Photoreceptor Protein Expression in Rd9
Immunohistochemical analysis of rhodopsin expression in Rd9/
Y mice at 2 months-of-age showed outer-segment labeling similar
Rd9 Mouse Model of RPGR-ORF15 Mutations
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e35865Figure 1. Identification of the genetic defect on the X-chromosome in Rd9 mice. A) Haplotype analysis showing the segregation patterns
of Rd9 and flanking markers in (CAST/Rd9)F1 x B6 backcrosses generating 364 meioses. Each column represents the chromosome inherited by a
group of backcross progeny, with black boxes representing BB homozygotes and white boxes denoting BC heterozygotes for a given locus. The
number of offspring that inherited the haplotype of that region of the X Chromosome is listed at the bottom of each column. Also shown is the
partial chromosome linkage map with the positions of Rd9 and its flanking markers. B) Chromatograms showing partial genomic sequence of Rpgr-
ORF15 in B6 and Rd9 mice, showing the location of a 32 bp duplication in the Rd9 strain. The precise location is difficult to define because of the
highly repetitive nature of the sequence. C) Comparison of Rpgr-ORF15 genomic sequences of B6, Rd9, and 129/SvJ mice determined by DNA
sequence analysis and aligned using ClustalW2. The B6 genomic sequence of Rpgr-ORF15 from the UCSC genome browser is also included. Additional
tandem duplications found in the Rd9 and 129/SvJ sequences are highlighted in yellow and blue. D) Alignment of Rpgr-ORF15 amino acid sequences
derived by translation of the B6, Rd9, and 129/SvJ genomic sequences, and the sequence of B6 from the UCSC Genome Browser. The sequences were
aligned using ClustalW2.
doi:10.1371/journal.pone.0035865.g001
Figure 2. RT-PCR and immunoblot analysis of Rpgr expression in mutant and wild-type mice. A) Schematic of the mouse Rpgr gene
showing the locations of the ORF15 exon, the oligonucleotide primers for RT-PCR, and protein sequences used to generate the RPGR antibodies S1
and S3. B) RT-PCR was performed on total retinal RNA from two-month-old male mice using a common exon 1 primer and reverse primers for ORF15
or exon 19. The PCR products were resolved on a 1% agarose gel. RT-PCR of Hprt was used as a control for RNA recovery and loading. C) Western
blots of retinal extracts from 2-6 month-old male B6 (wild type), Rd9, and Rpgr-KO mice probed with RPGR antibodies. The S1 antibody recognizes a
sequence common to both Rpgr ORF15 and 1–19 variants. The S3 antibody recognizes only the protein corresponding to the 1–19 variant.
doi:10.1371/journal.pone.0035865.g002
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at 12 months-of-age, rhodopsin staining in the superior retina
appeared diffuse and decreased in intensity, consistent with
decreased ROS integrity and/or protein stability with aging.
Extensive mislocalization of M-opsin within cones in the superior
retina was seen in Rd9/Y mice as young as 2 months-of-age, with
immunolabeling present throughout the cone inner segment,
perinuclear and synaptic regions. Mislocalization of M-opsin in the
inferior retina of Rd9/Y mice was evident in animals by 12
months-of-age (data not shown). In contrast, mislocalization of S-
opsin (largely expressed in the inferior retina) was not seen in Rd9/
Y mice up to 12 months-of-age, consistent with lesser disease
involvement in the inferior hemisphere.
Immunoblot analysis of total retinal protein extracts from 1-
month-old Rd9/Y and B6 mice showed equivalent levels of the
phototransduction proteins, transducin, arrestin, and recoverin,
but rhodopsin levels in Rd9/Y mice were reduced (Figure 5B).
Rhodopsin levels also appeared lower in ROS preparations from
Rd9/Y mice (Figure 5C), estimated by densitometry to be about
half of those present in ROS from B6 mice in samples with
equivalent protein loaded (Figure 5D).
Age-dependent Changes in Retinal Function in Rd9
ERG responses of Rd9 mice were similar in shape and timing to
those of wild-type B6 mice (Figure 6A). Although ERG amplitudes
decreased with age in Rd9/Y mice, characteristic waveforms were
retained up to 24 months-of-age. Intensity-response plots of dark-
adapted and light-adapted ERGs showed minimal increases in the
a- and b-wave thresholds with age, and were comparable to age-
dependent threshold variations observed in B6 mice up to 24-
months-old (Figure 6B, graphs a, b, and c). To analyze the ERG
responses of Rd9 and B6 mice, the rod photoreceptor-mediated
negative going a-wave was measured from the baseline to its
trough. The b-wave, which reflects bipolar cell activity, was
measured from the a-wave trough to the peak of the b-wave. The
dark-adapted ERG data were characterized by the rod saturated
b-wave amplitude, Vmax, and response sensitivity, k derived from
Naka-Rushton fits to the b-wave amplitude [40]. The mixed rod-
cone response was characterized by the b-wave amplitude Vbmax
and a-wave amplitude Vamax at maximum intensity of 1.09 log
cd.s.m
–2. The photopic ERG was characterized by the b-wave
amplitude Lmax at the maximum intensity. The ERG parameters
plotted as a function of age showed that at 1 month-of-age, Rd9
responses were comparable to those of B6 mice. Subsequently,
ERG amplitudes for Vamax,V b max,V max (data not shown), and
Lmax showed a gradual, progressive decline (Figure 6B, graphs d
and e). For statistical analysis, liner mixed regression was used to
adjust for correlated measures within a mouse over time. On
average, wild-type B6 mice had larger Vbmax than Rd9/Y mice
and this difference increased with age (p=0.0110). Vamax showed
a similar difference that increased with age between B6 and Rd9/
Y mice (p=0.0250). The photopic b-wave amplitude Lmax was
larger in B6 mice (p,0.0001) and this effect did not change with
age. Peak implicit time increased by 3 ms for Vamax, and by 7 ms
for Vbmax by 6 months-of-age in the Rd9/Y mice, but there was
no significant difference in the parameter k or in implicit time at
any age compared to B6 mice. Female Rd9/Rd9 mice showed a
slightly slower rate of decline, but all amplitudes matched those of
male Rd9/Y mice by 6 months-of-age. By 24 months-of-age, ERG
amplitudes of Rd9/Y males were reduced by 65% from the values
at 1 month-of-age. Effects of aging were also evident in the ERGs
of wild-type mice, as the values of the response amplitudes
obtained for B6 mice at 1 month-of-age were reduced by 35% in
animals at 24 months-of-age [41].
Figure 3. Immunohistochemical analysis of Rpgr in mutant and wild-type mice. Cryosections of eyes from 2-month-old B6, Rd9, and Rpgr-
KO male mice were probed with S1 antibody that recognizes a sequence common to both Rpgr ORF15 and 1–19 variants, and S3 antibody that
recognizes a sequence unique to the 1–19 variant. Red shows Rpgr-specific staining; blue shows DAPI staining of nuclei.
doi:10.1371/journal.pone.0035865.g003
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e35865Figure 4. Analysis of retinal histology in Rd9 and wild-type mice. A) Photographs of plastic retina sections from Rd9/Y and B6 mice at the
ages indicated. Morphometric analysis showing B) outer plus inner segment (OS+IS), and C) outer nuclear layer (ONL) thickness, in mice at 12
months-of-age. Thickness measurements were taken on sections parallel (superior/inferior) or orthogonal (nasal/temporal) to the vertical meridian of
eyes from Rd9/Y (#) and B6 (&) mice and plotted vs. distance from the optic nerve head, with standard deviations shown.
doi:10.1371/journal.pone.0035865.g004
Figure 5. Rhodopsin and cone opsin expression in Rd9 and wild-type mice. A) Immunohistochemical analysis of M-opsin, S-opsin, and
rhodopsin in the superior retina in Rd9/Y and B6 mice at 2 and 12 months-of-age (red fluorescence labeling). M-cone opsin reactivity appears
throughout both outer and inner segments in Rd9 mice at both ages. Rhodopsin reactivity is disturbed in Rd9 mice at 12 months-of-age. B) Western
analysis of rhodopsin, transducin-alpha subunit, arrestin, and recoverin in blots of total eye retinal protein homogenates from Rd9 and B6 mice at 1
month-of-age. The band corresponding to monomeric rhodopsin is shown, and b-actin served as a loading control. C) Immunoblot analysis of
rhodopsin, transducin, arrestin, and recoverin in ROS preparations from Rd9 and B6 mice. D) SyproRuby staining of ROS proteins separated by SDS-
PAGE verified equivalent loading of Rd9 and wild-type protein (b-actin, Hprt, and Gapdh were not informative markers for ROS preparations).
Representative results are shown (n=3). Rhodopsin (Rho), transducin-alpha subunit (GT-a), arrestin (Arr), and recoverin (Rcv).
doi:10.1371/journal.pone.0035865.g005
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e35865Figure 6. Electroretinogram (ERG) waveforms for Rd9 and wild-type mice. A) Representative dark-adapted and light-adapted ERGs
waveforms. For mice at 1 to 24 months-of-age, dark-adapted ERG recordings show the rod-mediated responses and maximal responses (rod plus
cone), and light-adapted ERG recordings show the maximal cone-mediated responses.B ) ERG intensity-response function V-Log I curves in Rd9 males
Rd9 Mouse Model of RPGR-ORF15 Mutations
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The dark-adapted ERG a-wave primarily reflects the photo-
response of rod photoreceptors [42,43], whereas the ERG b-wave
reflects bipolar activity postsynaptic to rods [44–46]. Therefore, to
assess inner retinal function and changes in visual signaling [47],
the dark-adapted b-wave amplitude normalized to the a-wave
amplitude (Vbmax/Vamax, or b/a-wave ratio) was determined at
each age. The b/a-wave ratio of male Rd9/Y mice was within
normal range up to about 6 months-of-age (Figure 6B, graph f ),
and was at the higher end of the normal range up to 24 months-of-
age, suggesting that both b-wave and a-wave amplitudes declined
at a similar rate at younger age. Female Rd9/Rd9 mice had larger
than normal b/a wave ratio at all ages. Vbmax was linearly
correlated to Vamax (R=0.95) (data not shown), indicating
linearity of signal transfer from rods to cones as the degeneration
progressed in Rd9/Y mice. Transient oscillatory potentials (OPs)
that are driven by inner retinal activity [48] were present even in
24-month-old Rd9/Y mice, although the amplitude of the sum of
OPs was reduced. To examine activity of the proximal retina, we
measured the cone-driven photopic negative response (PhNR) [38]
in Rd9/Y mice. The PhNR amplitude of Rd9/Y mice was
consistently lower than in wild-type B6 mice at all ages and was
down by 40% from the initial value at 1 month-of-age (data not
shown).
Correlation of Retinal Structure (disease) and Function
We used the relationship between the thickness of the
photoreceptor layer and the ERG parameters Vbmax and Vamax
to assess the stage of degeneration [49]. In Rd9/Y mice, the
OS+IS and ONL thicknesses were concordant with the ERG
amplitudes. The relationship between the ERG parameters Vbmax
and Vamax and OS+IS thickness could be described by a linear
function (Vbmax=–227.6+23.47*thickness, R= 0.96; and
Vamax=–138.9+11.34*thickness, R=0.95) (Figure S2). The slope
of Vbmax was nearly double that of Vamax indicating that Vbmax is
a more sensitive indicator of photoreceptor degeneration. We
found similar linear relationships between ONL and ERG
maximum amplitudes (Vbmax and Vamax).
Discussion
Our screening protocol identified Rd9 mice as a naturally-
occurring model of human RP3, an X-linked retinal degeneration
caused by mutations in RPGR. As in the majority of cases of RP3,
and in a significant fraction of males with simplex RP [3], retinal
degeneration in Rd9 mice is caused by a mutation in the
alternatively-spliced exon ORF15. This exon encodes a protein
domain that is unique to the RPGR isoform present in the
connecting cilia of photoreceptors and features a 154 amino acid
region (in B6 mice) composed almost entirely of EEEGEG repeats.
This region is encoded by a similarly repetitive genomic DNA with
a near absence of pyrimidines (7 pyrimidines in 462 nucleotides).
The 32-bp duplication identified in the ORF15 region of Rd9
mice is predicted to alter the reading frame and lead to a truncated
Rpgr-ORF15 protein in which the C-terminal 108 amino acids
are out-of-frame. In contrast to the highly acidic nature of the
normal reading frame, the amino-acid residues after the frame
shift in Rd9 are predominantly basic. The ORF15 mutant protein
appears to be unstable and is not detected in Rd9 retinal extracts
or connecting cilia. Although wild-type levels of the constitutive
isoform Rpgr 1-19 appear to be retained in Rd9 retinal lysates, the
levels detected in Rd9 photoreceptor cells appear to be decreased,
possibly due to reduced cellular functions associated with the more
abundant ORF15 variant.
The retinal phenotype of Rd9 mice is relatively mild compared
to that present in RP3 individuals, yet it shares several important
features in common with the human disease. These include the
presence of retinal pathology and reduction of ERG function at
early ages. Our analysis of the natural history and time course of
disease progression in Rd9 mice show that rod and cone ERG
amplitudes were reduced as early as 6 weeks-of-age in both male
Rd9/Y and female Rd9/Rd9 mice, consistent with the expression
of RPGR in both rods and cones. As we moved into new mouse
quarters, we repeated the ERG analysis on eight males and four
females for up to six months to further confirm the initial decreases
in amplitude. Amplitude reductions in all ERG parameters were
reproducible; however, the reduction from controls seen in the first
four months was 25% compared to 35% in the initial study
(Fig. 6B, graph d). Loss of amplitudes observed at young ages may
be due to one or more mechanisms, including defects in
photoreceptor OS and IS formation [50]. The decline in
amplitudes occurring during aging correlated well with the
reduction in ONL thickness, suggesting that photoreceptor cell
loss is a contributing factor. Rd9/Y mice exhibited larger b/a-
wave ratios compared to wild-type at later ages, suggesting that
photoreceptor cell dysfunction predominates over inner retinal
changes. Inner retinal abnormalities in RPGR-XLRP have been
documented in humans [51] and in dogs [28] in the form of
thickening of inner retinal structures secondary to ONL loss.
Although we did not perform cell counts, the inner retina and
ganglion cell layers of the Rd9/Y male mice showed no obvious
loss by light microscopy.
The natural history of the Rd9 mouse is very similar to that
previously reported for the Rpgr-KO mouse [26]. Unlike the Rpgr-
KO mouse, the Rd9 retina retains the expression of the Rpgr 1-19
constitutive isoform. In both models, disease progression features
rod pathology that develops progressively over a two year period,
as well as cone opsin mislocalization that is evident from early ages
onward. These similarities may be due to the fact that neither
model expresses detectable Rpgr-ORF15 protein, albeit by
different mechanisms. Unlike the Rpgr-KO mouse, the Rd9 retina
retains the expression of the Rpgr 1–19 constitutive isoform. Thus,
it appears that low level expression of the constitutive isoform in
photoreceptors does not fully compensate for the absence of the
ORF15 variant in Rd9 mice.
Mislocalization of rod and cone opsins is observed in post-
mortem eyes from RP3 carriers [52,53], XLPRA dogs with two
different mutations in ORF15 [28], and in two other genetically
independent strains of Rpgr-mutant mice [26,27]. For mice in
which Rpgr exon 4 was deleted, genetic background was found to
play a major role in determining the extent of rod and cone
involvement, with rod disease predominating on the B6 back-
ground, and cone disease predominating on the albino BALB/cJ
background [27]. Although cone-opsin mislocalization is an early
hallmark of photoreceptor dysfunction associated with RPGR
mutations, the underlying mechanism is not understood and
(open symbols) at 1 (n= 10), 1.5 (n=6), 2 (n=13), 4 (n=11), 12 (n=11), and 24 months (n=5) compared to 1-month-old B6 mice (filled squares). a)
dark-adapted a-wave. b) dark-adapted b-wave. c) photopic b-wave. Natural history of maximum ERG amplitude (Mean 6 SE) changes in Rd9/Y males,
Rd9/Rd9 females, and B6 mice. d) Dark-adapted Vamax and Vbmax. e) Photopic Lmax. f) b/a wave ratio. Grey area represents the wild-type normal
range.
doi:10.1371/journal.pone.0035865.g006
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mislocalization of cone opsin was correlated to the absence of 11-
cis retinal, and this defect could be corrected by administration of
exogenous chromophore [54]. In RPGR mutant dogs, evidence of
abnormal photoreceptor maturation resulting in abnormal outer
segment structures was seen [50], a factor which could contribute
to the decrease in rhodopsin levels such as those seen in young
Rd9/Y mice. Rhodopsin labeling appears increasingly disrupted
with aging, suggesting that RPGR mutations also impact rod outer
segment stability. Studies of the recombinant ORF15 protein in
XLPRA2 indicate that rod-cone degeneration may result from
aggregation of the mutant protein and its retention in the
endoplasmic reticulum [28].
While there are no histopathologic studies of affected male
patients with RPGR mutations, fundus abnormalities and histo-
pathological reports in female carriers have shown a multifocal
pattern of retinal dysfunction and disease, including opsin
mislocalization and loss of photoreceptor nuclei [52,53] similar
to that seen in canine XLPRA2 and XLPRA1 carriers [55]. Autopsy
eyes of three carrier individuals (age 75 to 86 years) revealed
retinal pigment epithelium (RPE) abnormalities, including atrophy
or proliferation, focal loss, and subretinal and intraretinal
migration [56]. The autopsy eyes exhibited a patchy pattern of
photoreceptor degeneration, and relative sparing of cones
compared to rods, reduced or absent cone outer segments, and
broad cone inner segments. Neurite sprouting from rods was also
observed in a carrier with an RPGR-ORF15 Glu210 mutation.
Human studies have also shown variable disease expression in
female carriers, with some carriers of RPGR exon ORF15
mutations being severely affected while others manifest an
asymmetric phenotype or are asymptomatic [57].
Clinical studies of males with XLRP due to mutations in RPGR
show that patients have an earlier loss of visual acuity and visual
fields compared to most other types of RP [58]. A recent study
documented a wide range of clinical severity in 98 affected males
[59]. Genetic factors such as allelic heterogeneity and genetic
modifiers were shown to contribute to this diversity. Individuals
with mutations in RPGR exons 1 to 14 have a more severe
phenotype than those carrying ORF15 mutations [58–60]. In a
large patient cohort followed over 8 years, ERG amplitudes
declined 50% faster in individuals with mutations in exons 1–14
compared to those with ORF15 mutations; however, visual acuity
and visual field loss were comparable in both groups [58]. Loss of
acuity was attributed to photoreceptor cell loss detected by optical
coherence tomography (OCT). In another study of two patients
with RPGR mutations, in vivo microscopy revealed impaired rod,
and well-preserved cone, function in early-stage disease, and
absence of rod and cone function, and a deep foveal pit due to
photoreceptor cell loss, in late-stage disease [61]. Our analysis of
Rd9/Y male and Rd9/Rd9 female mice shows that disease caused
by Rpgr-ORF15 mutations exhibits a uniform phenotype,
beginning at very young ages and progressing gradually. In
previous studies of the RPGR canine mutants, XLPRA1 animals
exhibited slow rod and cone photoreceptor degeneration, whereas
XLPRA2 animals exhibited abnormal photoreceptor development
and rapid degeneration [28,55]. Although the human phenotype is
highly variable, disease onset generally occurs at a greater relative
age and progresses rapidly compared to the animal models.
Differences in the rates of animal and human development in early
life, and inconsistencies between age-of-onset and age-of-diagnosis,
however, make direct comparisons of disease severity relative to
lifespan difficult.
XLRP caused by mutations in RPGR-ORF15 represents a
significant portion of all inherited retinal degenerations, making it
an important focus of basic and translational research. The disease
in Rd9 mice appears to be milder than in individuals with RP3,
but shares a number of important features in common that
validate this naturally occurring mouse strain as an important
model of the human disease. These include a frame-shift mutation
in ORF15, mislocalization of opsin to the cone inner segments,
reduction of ERG function at early ages, and progressive loss of
ERG amplitudes with aging. We anticipate that the Rd9 model of
XLRP will become a valuable addition to the tools available for
analysis of RPGR function, associated disease pathogenesis, and
the development of novel therapeutic strategies.
Supporting Information
Figure S1 Retina images. A) Fundus photographs of wild-
type and mice with the Rd9 genotypes indicated at 5 months-of-
age. B) Following injection, fluorescein dye shows telangiectasia
and some leakage from vessels in the Rd9 mice.
(TIF)
Figure S2 Correlation of scotopic a-wave (Vamax) and
b-wave (Vbmax) maximum amplitude with IS plus OS
thickness in Rd9 mice.
(TIF)
Table S1 Primers used to PCR amplify and sequence
mouse Rpgr.
(DOC)
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